Market Access Views & Analysis

Views & Analysis

Market Access

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in a specific t

Market Access

Rethinking value: why diverse viewpoints matter

Value is a tricky concept to capture accurately.

Market Access

Saving lives doesn’t have to cost the Earth

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come t

Market Access

Deep Dive: Market Access

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge.

Market Access

Why companies don’t submit to NICE

In March 2022, Leela Barham argued that, in light o

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Medical Informatics and Rare Disease: a bridge between two w...

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve th

Leveraging KOL insights to succeed in a data-driven world

Rethinking value: why diverse viewpoints matter

Saving lives doesn’t have to cost the Earth

Deep Dive: Market Access

Why companies don’t submit to NICE

Medical Informatics and Rare Disease: a bridge between two w...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks